Harvard Bioscience Inc (HBIO)
2.72
+0.06
(+2.26%)
USD |
NASDAQ |
Sep 27, 16:00
2.715
0.00 (0.00%)
After-Hours: 20:00
Harvard Bioscience Research and Development Expense (Annual): 11.76M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 11.76M |
| December 31, 2022 | 12.33M |
| December 31, 2021 | 10.80M |
| December 31, 2020 | 8.685M |
| December 31, 2019 | 10.72M |
| December 31, 2018 | 10.99M |
| December 31, 2017 | 5.645M |
| December 31, 2016 | 5.392M |
| December 31, 2015 | 6.42M |
| December 31, 2014 | 4.88M |
| December 31, 2013 | 4.154M |
| December 31, 2012 | 4.344M |
| December 31, 2011 | 3.874M |
| Date | Value |
|---|---|
| December 31, 2010 | 4.669M |
| December 31, 2009 | 4.396M |
| December 31, 2008 | 4.048M |
| December 31, 2007 | 3.708M |
| December 31, 2006 | 3.154M |
| December 31, 2005 | 2.95M |
| December 31, 2004 | 2.981M |
| December 31, 2003 | 6.263M |
| December 31, 2002 | 4.146M |
| December 31, 2001 | 3.179M |
| December 31, 2000 | 1.533M |
| December 31, 1999 | 1.188M |
| December 31, 1998 | 0.325M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
8.685M
Minimum
2020
12.33M
Maximum
2022
10.86M
Average
10.80M
Median
2021
Research and Development Expense (Annual) Benchmarks
| Bruker Corp | 294.80M |
| Azenta Inc | 33.96M |
| Bionano Genomics Inc | 54.03M |
| Akoya Biosciences Inc | 21.89M |
| Singular Genomics Systems Inc | 47.76M |